Summary
For Year 2026-27, Natco Pharma reports the following shareholding: Total Promoters at 49.42%, Mutual Fund at 1.72%, Insurance at 3.27%, Foreign Institutional Investors at 17.37%, Domestic Institutional Investors at 0.46%, and Retail at 27.76%. This breakdown provides a quick snapshot of ownership distribution for Natco Pharma in 2026-27.
Natco Pharma FAQs
As of 04-2026, the promoter shareholding in Natco Pharma stands at 49.42% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Natco Pharma is 17.37% and 0.46% respectively.
The retail shareholding of the Natco Pharma is 27.76%.
Changes in shareholding patterns of Natco Pharma can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Natco Pharma are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
